Page last updated: 2024-08-22

ferrous sulfate and Uterine Neoplasms

ferrous sulfate has been researched along with Uterine Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, J; Morris, T; Muneyyirci-Delale, O; Richard-Davis, G	1
Friedman, AJ	1

Trials

1 trial(s) available for ferrous sulfate and Uterine Neoplasms

Article	Year
Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Clinical therapeutics, 2007, Volume: 29, Issue:8 Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Female; Ferrous Compounds; Goserelin; Gynecologic Surgical Procedures; Hematinics; Hemoglobins; Humans; Injections, Subcutaneous; Leiomyoma; North America; Premedication; Premenopause; Time Factors; Treatment Outcome; Uterine Neoplasms	2007

Article

Year

Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.

Clinical therapeutics, 2007, Volume: 29, Issue:8

Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Female; Ferrous Compounds; Goserelin; Gynecologic Surgical Procedures; Hematinics; Hemoglobins; Humans; Injections, Subcutaneous; Leiomyoma; North America; Premedication; Premenopause; Time Factors; Treatment Outcome; Uterine Neoplasms

2007

Other Studies

1 other study(ies) available for ferrous sulfate and Uterine Neoplasms

Article	Year
Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas. Human reproduction (Oxford, England), 1993, Volume: 8, Issue:4 Topics: Adult; Contraceptives, Oral; Delayed-Action Preparations; Drug Therapy, Combination; Estrogens; Female; Ferrous Compounds; Gonadotropin-Releasing Hormone; Hemorrhage; Humans; Leiomyoma; Leuprolide; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms; Vaginal Diseases	1993

Article

Year

Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.

Human reproduction (Oxford, England), 1993, Volume: 8, Issue:4

Topics: Adult; Contraceptives, Oral; Delayed-Action Preparations; Drug Therapy, Combination; Estrogens; Female; Ferrous Compounds; Gonadotropin-Releasing Hormone; Hemorrhage; Humans; Leiomyoma; Leuprolide; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms; Vaginal Diseases

1993